Dyne Therapeutics (DYN) Shares Issued (2020 - 2026)

Dyne Therapeutics' Shares Issued history runs 7 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• In Q1 2026, Shares Issued fell 99.07% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $379.0 million (up 66.52% YoY), while the FY2025 annual figure was $140.7 million, up 43.71% from the prior year.
• Shares Issued was $1.3 million for Q1 2026 at Dyne Therapeutics, down from $377.7 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $377.7 million in Q4 2025 to a low of -$138.1 million in Q2 2025.
• Historically, Shares Issued has averaged $41.0 million across 5 years, with a median of $6.1 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Shares Issued surged 52206.06% in 2023, then tumbled 258.81% in 2025.
• A 5-year view of Shares Issued shows it stood at $36.7 million in 2022, then tumbled by 237.47% to -$50.4 million in 2023, then jumped by 228.26% to $64.7 million in 2024, then surged by 484.11% to $377.7 million in 2025, then slumped by 99.65% to $1.3 million in 2026.
• The last three Shares Issued figures came in at $1.3 million (Q1 2026), $377.7 million (Q4 2025), and $138.1 million (Q3 2025), per Business Quant data.